ArticleMovement disorders clinical practice2025

An Open-Label, Non-randomized, Drug-Repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease.

Sofia Bordet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.